Kynam Capital Management, LP Ironwood Pharmaceuticals Inc Transaction History
Kynam Capital Management, LP
- $837 Million
- Q2 2025
A detailed history of Kynam Capital Management, LP transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Kynam Capital Management, LP holds 5,466,825 shares of IRWD stock, worth $5.36 Million. This represents 0.47% of its overall portfolio holdings.
Number of Shares
5,466,825
Previous 5,822,938
6.12%
Holding current value
$5.36 Million
Previous $8.56 Million
54.01%
% of portfolio
0.47%
Previous 0.72%
Shares
6 transactions
Others Institutions Holding IRWD
# of Institutions
178Shares Held
169MCall Options Held
11.2MPut Options Held
0-
Black Rock Inc. New York, NY22.9MShares$22.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.2MShares$15.9 Million0.0% of portfolio
-
Armistice Capital, LLC New York, NY16.2MShares$15.8 Million0.2% of portfolio
-
Sarissa Capital Management LP Greenwich, CT15.9MShares$15.6 Million8.54% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.41MShares$8.24 Million0.01% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $150M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...